Breast cancer screening and diagnosis

TB Bevers, BO Anderson, E Bonaccio, S Buys… - Journal of the National …, 2009 - jnccn.org
Women in the United States have a 12.3% estimated lifetime risk for developing breast
cancer (ie, 1 in 8 women). 1 In 2009, an estimated 194,290 cases of invasive breast cancer …

Breast cancer screening and diagnosis, version 3.2018, NCCN clinical practice guidelines in oncology

TB Bevers, M Helvie, E Bonaccio, KE Calhoun… - Journal of the National …, 2018 - jnccn.org
The NCCN Guidelines for Breast Cancer Screening and Diagnosis have been developed to
facilitate clinical decision making. This manuscript discusses the diagnostic evaluation of …

[HTML][HTML] Upgrade rates of high-risk breast lesions diagnosed on core needle biopsy: a single-institution experience and literature review

KL Mooney, LW Bassett, SK Apple - Modern Pathology, 2016 - Elsevier
Optimal management of high-risk breast lesions detected by mammogram yielding atypical
ductal hyperplasia, flat epithelial atypia, atypical lobular hyperplasia, lobular carcinoma in …

Observation versus excision of lobular neoplasia on core needle biopsy of the breast

H Schmidt, B Arditi, M Wooster, C Weltz… - Breast cancer research …, 2018 - Springer
Purpose Controversy surrounds management of lobular neoplasia (LN),[atypical lobular
hyperplasia (ALH) or lobular carcinoma in situ (LCIS)], diagnosed on core needle biopsy …

Core breast biopsies showing lobular carcinoma in situ should be excised and surveillance is reasonable for atypical lobular hyperplasia

LQC Sen, WA Berg, RJ Hooley… - American Journal of …, 2016 - Am Roentgen Ray Soc
OBJECTIVE. The purpose of this article is to determine the upgrade rate to ductal carcinoma
in situ (DCIS) or invasive carcinoma at excision at the same site after percutaneous breast …

Current concepts in diagnosis, molecular features, and management of lobular carcinoma in situ of the breast with a discussion of morphologic variants

PS Ginter, TM D'Alfonso - Archives of Pathology & …, 2017 - meridian.allenpress.com
Context.—Lobular carcinoma in situ (LCIS) refers to a neoplastic proliferation of cells that
characteristically shows loss of E-cadherin expression and has long been regarded as a risk …

Risk for upgrade to malignancy after breast core needle biopsy diagnosis of lobular neoplasia: a systematic review and meta-analysis

MN Shehata, H Rahbar, MR Flanagan… - Journal of the American …, 2020 - Elsevier
Purpose Lobular neoplasia (LN) detected on breast core needle biopsy is frequently
managed with surgical excision because of concern for undersampled malignancy. The …

Pathologic upgrade rates on subsequent excision when lobular carcinoma in situ is the primary diagnosis in the needle core biopsy with special attention to the …

TM D'Alfonso, K Wang, YL Chiu… - Archives of Pathology …, 2013 - meridian.allenpress.com
Context.—Lobular carcinoma in situ (LCIS) as the primary pathologic diagnosis in a needle
core biopsy is an infrequent finding, and the management of patients in this setting is …

Controversies on the management of high-risk lesions at core biopsy from a radiology/pathology perspective

D Georgian-Smith, TJ Lawton - Radiologic Clinics, 2010 - radiologic.theclinics.com
America by Berg. 1 Adding more retrospective reviews will take us no closer to discovering
the truth, and yet such studies are ongoing. The solution is a prospective, multi-institutional …

Lobular neoplasia and atypical ductal hyperplasia on core biopsy: current surgical management recommendations

JM Racz, JM Carter, AC Degnim - Annals of surgical oncology, 2017 - Springer
Lobular neoplasia and atypical ductal hyperplasia (ADH) are high-risk breast lesions
associated with an increased risk of breast cancer. Until recently, surgical excision was …